Therapy targeted to the NLRP3 inflammasome in chronic kidney disease
Background: The NLRP3 inflammasome is a cytoplasmic polymeric protein complex composed of the cytoplasmic sensor NLRP3, the apoptosis-related spot-like protein ASC, and the inflammatory protease caspase-1. NLRP3 activates and releases IL-1β through classical pathways, and IL-18 mediates inflammation...
Saved in:
Main Authors: | Yong Ji (Author), Hu Hua (Author), Zhanjun Jia (Author), Aihua Zhang (Author), Guixia Ding (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation
by: Mingzhu Jiang, et al.
Published: (2021) -
NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
by: Pengfei Chen, et al.
Published: (2024) -
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
by: Ozaki E, et al.
Published: (2015) -
Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
by: Nan Ding, et al.
Published: (2020) -
The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets
by: Tao Liang, et al.
Published: (2022)